NDC 68682-272

Imiquimod

Imiquimod

Imiquimod is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Oceanside Pharmacueticals. The primary component is Imiquimod.

Product ID68682-272_a97d5ae0-1ef7-4b0c-94e5-1f0ce9cb0fba
NDC68682-272
Product TypeHuman Prescription Drug
Proprietary NameImiquimod
Generic NameImiquimod
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2018-06-27
Marketing CategoryNDA / NDA AUTHORIZED GENERIC
Application NumberNDA022483
Labeler NameOceanside Pharmacueticals
Substance NameIMIQUIMOD
Active Ingredient Strength38 mg/g
Pharm ClassesIncreased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68682-272-75

1 BOTTLE, PUMP in 1 CARTON (68682-272-75) > 7.5 g in 1 BOTTLE, PUMP
Marketing Start Date2018-06-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68682-272-75 [68682027275]

Imiquimod CREAM
Marketing CategoryNDA
Application NumberNDA022483
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2018-06-27

Drug Details

Active Ingredients

IngredientStrength
IMIQUIMOD37.5 mg/g

OpenFDA Data

SPL SET ID:d86eeb0e-70e0-4c72-aaa3-37daa1d8611e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 967017
  • Pharmacological Class

    • Increased Cytokine Activity [PE]
    • Increased Cytokine Production [PE]
    • Interferon Inducers [MoA]

    NDC Crossover Matching brand name "Imiquimod" or generic name "Imiquimod"

    NDCBrand NameGeneric Name
    0093-3133Imiquimodimiquimod
    0168-0432imiquimodimiquimod
    45802-368ImiquimodImiquimod
    51672-4145ImiquimodImiquimod
    51672-4174ImiquimodImiquimod
    52549-4145ImiquimodImiquimod
    63629-8818Imiquimodimiquimod
    64380-773imiquimodimiquimod
    68462-536ImiquimodImiquimod
    68682-272Imiquimodimiquimod
    72189-084IMIQUIMODIMIQUIMOD
    99207-260Aldaraimiquimod
    99207-270Zyclaraimiquimod
    99207-271Zyclaraimiquimod
    99207-276Zyclaraimiquimod

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.